Brewin Dolphin Wealth Management LTD Amgen Inc Transaction History

Brewin Dolphin Wealth Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Nov 09, 2023	SELL	$233.58 - $259.14 $33,401 - $37,057	-143 Closed	0 $0
Q1 2021 Nov 09, 2023	BUY	$221.91 - $258.6 $31,733 - $36,979	143 New	143 $35.6 Million
Q4 2020 Nov 09, 2023	SELL	$216.38 - $257.67 $31,158 - $37,104	-144 Closed	0 $0
Q3 2020 Nov 09, 2023	BUY	$234.65 - $260.95 $7,039 - $7,828	30 Added 26.32%	144 $36.6 Million
Q2 2020 Nov 09, 2023	BUY	$197.81 - $242.74 $22,550 - $27,672	114 New	114 $26.9 Million

2,933

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Brewin Dolphin Wealth Management LTD, based on Form 13F filings with the SEC.

Stay updated on Brewin Dolphin Wealth Management LTD with notifications on news.